Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nymox Pharmaceutical Corp. (NYMX)
NASDAQ:NYMX
Nymox Pharmaceutical (NYMX) Stock Price & Analysis
0 Followers
NYMX Stock Chart & Stats
Day’s Range$0.18 - $0.22
52-Week Range― - ―
Previous Close$0.25
Volume932.74K
Average Volume (3M)N/A
Market Cap
$38.02M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding90,520,000
10 Day Avg. Volume642,563
30 Day Avg. Volume230,465
Standard Deviation0.22
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)-0.13
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nymox Pharmaceutical News
PremiumPress Releases
NYMOX Update
PremiumPress Releases
Nymox Delisting from NASDAQ
PremiumPress Releases
Nymox Provides Current Update
PremiumPress Releases
Nymox Provides Corporate Update
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NYMX FAQ
What was Nymox Pharmaceutical Corp.’s price range in the past 12 months?
Currently, no data Available
What is Nymox Pharmaceutical Corp.’s market cap?
Currently, no data Available
When is Nymox Pharmaceutical Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nymox Pharmaceutical Corp.’s earnings last quarter?
Currently, no data Available
Is Nymox Pharmaceutical Corp. overvalued?
According to Wall Street analysts Nymox Pharmaceutical Corp.’s price is currently Overvalued.
Does Nymox Pharmaceutical Corp. pay dividends?
Nymox Pharmaceutical Corp. does not currently pay dividends.
What is Nymox Pharmaceutical Corp.’s EPS estimate?
Nymox Pharmaceutical Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nymox Pharmaceutical Corp. have?
Currently, no data Available
What happened to Nymox Pharmaceutical Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nymox Pharmaceutical Corp.?
Currently, no hedge funds are holding shares in NYMX
---
Nymox Pharmaceutical Stock Smart Score
Company Description
Nymox Pharmaceutical Corp.
Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
---
Technical Analysis
Apellis Pharmaceuticals
―
Brainstorm Cell Therapeutics
―
Corvus Pharmaceuticals
―
Eyenovia
―
---